104 related articles for article (PubMed ID: 12737641)
1. Adherence to HIV antiretrovirals among persons with serious mental illness.
Wagner GJ; Kanouse DE; Koegel P; Sullivan G
AIDS Patient Care STDS; 2003 Apr; 17(4):179-86. PubMed ID: 12737641
[TBL] [Abstract][Full Text] [Related]
2. Correlates of HIV antiretroviral adherence in persons with serious mental illness.
Wagner GJ; Kanouse DE; Koegel P; Sullivan G
AIDS Care; 2004 May; 16(4):501-6. PubMed ID: 15203417
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with accurate self-reported adherence to HIV antiretrovirals.
Kimmerling M; Wagner G; Ghosh-Dastidar B
Int J STD AIDS; 2003 Apr; 14(4):281-4. PubMed ID: 12716500
[TBL] [Abstract][Full Text] [Related]
5. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population.
Palmer NB; Salcedo J; Miller AL; Winiarski M; Arno P
AIDS Patient Care STDS; 2003 Dec; 17(12):635-44. PubMed ID: 14746657
[TBL] [Abstract][Full Text] [Related]
7. Barriers to use of electronic adherence monitoring in an HIV clinic.
Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
[TBL] [Abstract][Full Text] [Related]
8. Placebo practice trials: a tool to assess and improve adherence readiness.
Wagner G; Iguchi M; Schneider S; Scott J; Anderson D
HIV Clin Trials; 2002; 3(6):475-81. PubMed ID: 12501131
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness.
Blank MB; Hanrahan NP; Fishbein M; Wu ES; Tennille JA; Ten Have TR; Kutney-Lee AM; Gross R; Hines JM; Coyne JC; Aiken LH
Psychiatr Serv; 2011 Nov; 62(11):1318-24. PubMed ID: 22211211
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.
Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE
Clin Infect Dis; 2001 Oct; 33(8):1417-23. PubMed ID: 11550118
[TBL] [Abstract][Full Text] [Related]
11. Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults.
Shuter J; Sarlo JA; Stubbs RO; Rode RA; Zingman BS
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):94-7. PubMed ID: 22223595
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic medications and HIV.
Thompson A; Silverman B; Dzeng L; Treisman G
Clin Infect Dis; 2006 May; 42(9):1305-10. PubMed ID: 16586391
[TBL] [Abstract][Full Text] [Related]
13. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
Grossberg R; Zhang Y; Gross R
J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
[TBL] [Abstract][Full Text] [Related]
14. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
15. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.
Mellins CA; Havens JF; McDonnell C; Lichtenstein C; Uldall K; Chesney M; Santamaria EK; Bell J
AIDS Care; 2009 Feb; 21(2):168-77. PubMed ID: 19229685
[TBL] [Abstract][Full Text] [Related]
16. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial.
Weber R; Christen L; Christen S; Tschopp S; Znoj H; Schneider C; Schmitt J; Opravil M; Günthard HF; Ledergerber B;
Antivir Ther; 2004 Feb; 9(1):85-95. PubMed ID: 15040540
[TBL] [Abstract][Full Text] [Related]
17. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
Wagner GJ; Rabkin JG
AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
[TBL] [Abstract][Full Text] [Related]
18. Use of HIV and psychotropic medications among persons with serious mental illness and HIV/AIDS.
Lee S; Rothbard AB; Noll E; Blank MB
Adm Policy Ment Health; 2011 Sep; 38(5):335-44. PubMed ID: 20976619
[TBL] [Abstract][Full Text] [Related]
19. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
[TBL] [Abstract][Full Text] [Related]
20. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
Fairley CK; Permana A; Read TR
HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
